Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany

• Main Authors: Desmond Curran (Author), Desirée Van Oorschot (Author), Sean Matthews (Author), Johannes Hain (Author), Ahmed Ehab Salem (Author), Magdalena Schwarz (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The aim of the study was to update previously published public health impact and cost-effectiveness analyses of the recombinant zoster vaccine (RZV), in the German population aged ≥50 years of age (YOA), with the latest vaccine efficacy (VE) estimates against herpes zoster (HZ). The updated estimate...